EnglishMARASCA, Roberto
Risultati 1 - 20 di 177 (tempo di esecuzione: 0.0 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line. | 2009 | Galimberti, S; Canestraro, M; Maffei, Rossana; Marasca, Roberto; Guerrini, F; Piaggi, S; Ciabatti, E; Petrini, M. |
| 2 | Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines | 2008 | GALIMBERTI S; CANESTRARO M; KHAN R; BUDA G; ORCIUOLO E; GUERRINI F; FAZZI R; MAFFEI R; R. MARASCA; PETRINI M |
| 3 | A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome | 2011 | Rasi S; Spina V; Bruscaggin A; Vaisitti T; Tripodo C; Forconi F; De Paoli L; Fangazio M; Sozzi E; Cencini E; Laurenti L; Marasca R; Visco C; Xu-Monette ZY; Gattei V; Young KH; Malavasi F; Deaglio S; Gaidano G; Rossi D |
| 4 | An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? | 2014 | Bigliardi, S; Morselli, M; Potenza, L; Bresciani, P; Cuoghi, A; Coluccio, V; Riva, G; Paolini, A; Fantuzzi, V; Faglioni, L; Nasillo, V; Messerotti, A; Marasca, R; Narni, F; Luppi, M; Forghieri, F |
| 5 | Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome | 2013 | Chigrinova, Ekaterina; Rinaldi, Andrea; Kwee, Ivo; Rossi, Davide; Rancoita, Paola M V; Strefford, Jonathan C; Oscier, David; Stamatopoulos, Kostas; Papadaki, Theodora; Berger, Francoise; Young, Ken H; Murray, Fiona; Rosenquist, Richard; Greiner, Timothy C; Chan, Wing C; Orlandi, Ester M; Lucioni, Marco; Marasca, Roberto; Inghirami, Giorgio; Ladetto, Marco; Forconi, Francesco; Cogliatti, Sergio; Votavova, Hana; Swerdlow, Steven H; Stilgenbauer, Stephan; Piris, Miguel A; Matolcsy, Andras; Spagnolo, Dominic; Nikitin, Eugene; Zamò, Alberto; Gattei, Valter; Bhagat, Govind; Ott, German; Zucca, Emanuele; Gaidano, Gianluca; Bertoni, Francesco |
| 6 | Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) | 2011 | Riva, Giovanni; Belletti, Daniela; Ruozi, Barbara; Barozzi, Patrizia; Vallerini, Daniela; Quadrelli, Chiara; Zanetti, Eleonora; Morselli, M; Forghieri, Fabio; Marasca, Roberto; Narni, Franco; Tosi, Giovanni; Forni, Flavio; Vandelli, Maria Angela; Potenza, Leonardo; Luppi, Mario |
| 7 | Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia | 2014 | Wang, Jiguang; Khiabanian, Hossein; Rossi, Davide; Fabbri, Giulia; Gattei, Valter; Forconi, Francesco; Laurenti, Luca; Marasca, Roberto; Del Poeta, Giovanni; Foà, Robin; Pasqualucci, Laura; Gaidano, Gianluca; Rabadan, Raul |
| 8 | Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib | 2015 | Maffei, Rossana; Fiorcari, Stefania; Martinelli, Silvia; Potenza, Leonardo; Luppi, Mario; Marasca, Roberto |
| 9 | Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo | 1995 | Giuseppe Torelli;Patrizia Barozzi;Roberto Marasca;Paola Cocconcelli;Elisa Merelli;Luca Ceccherini-Nelli;Sergio Ferrari;Mario Luppi |
| 10 | SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI | 2007 | Santachiara, R.; Leonardi, G.; Vallisa, D.; Maffei, R.; Martinelli, S.; Ferrari, A.; Alfieri, P.; Luppi, G.; Bertolini, F.; Piacentini, F.; Marasca, R.; Torelli, G. |
| 11 | Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status | 2006 | Thorselius M; Krober A; Murray F; Thunberg U; Tobin G; Buhler A; Kienle D; Albesiano E; Maffei R; Dao-Ung LP; Wiley J; Vilpo J; Laurell A; Merup M; Roos G; Karlsson K; Chiorazzi N; Marasca R; Dohner H; Stilgenbauer S; Rosenquist R |
| 12 | Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. | 2010 | Zibellini, S; Capello, D; Forconi, F; Marcatili, P; Rossi, D; Rattotti, S; Franceschetti, S; Sozzi, E; Cencini, E; Marasca, Roberto; Baldini, L; Tucci, A; Bertoni, F; Passamonti, F; Orlandi, E; Varettoni, M; Merli, M; Rizzi, S; Gattei, V; Tramontano, A; Paulli, M; Gaidano, G; Arcaini, L. |
| 13 | Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. | 2009 | Rossi, D; Spina, V; Cerri, M; Rasi, S; Deambrogi, C; De Paoli, L; Laurenti, L; Maffei, Rossana; Forconi, F; Bertoni, F; Zucca, E; Agostinelli, C; Cabras, A; Lucioni, M; Martini, M; Magni, M; Deaglio, S; Ladetto, M; Nomdedeu, Jf; Besson, C; Ramponi, A; Canzonieri, V; Paulli, M; Marasca, Roberto; Larocca, Lm; Carbone, A; Pileri, Sa; Gattei, V; Gaidano, G. |
| 14 | Spontaneous loss of Ph chromosome with maintenance of clonal hemopoiesis in an untreated patient with myeloproliferative disease and a long survival. | 1995 | Luppi M; Morselli M; Emilia G; Temperani P; Marasca R; Barozzi P; Selleri L; Torelli G. |
| 15 | Spontaneous adrenal gland haematoma in a patient with antiphospholipid antibodies | 1995 | Luppi M; Marasca R; Torricelli P; Leonardi G; Gavioli GL; Bocchi A; Torelli G. |
| 16 | Severe anemia in a patient with multiple sclerosis treated with natalizumab | 2014 | Simone, Anna Maria; Ferraro, Diana; Vitetta, Francesca; Marasca, Roberto; Bonacorsi, Goretta; Pinelli, Giovanni; Federzoni, Lucia; Nichelli, Paolo Frigio; Sola, Patrizia |
| 17 | Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene | 1996 | Luppi, Mario; Morselli, M; Bandieri, E; Federico, Massimo; Marasca, Roberto; Barozzi, P; Ferrari, Mg; Savarino, M; Frassoldati, A; Torelli, Giuseppe |
| 18 | Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study | 2016 | Arcari, Annalisa; Chiappella, Annalisa; Spina, Michele; Zanlari, Luca; Bernuzzi, Patrizia; Valenti, Vanessa; Tani, Monica; Marasca, Roberto; Cabras, Maria Giuseppina; Zambello, Renato; Santagostino, Alberto; Ilariucci, Fiorella; Carli, Giuseppe; Musto, Pellegrino; Savini, Paolo; Marino, Dario; Ghio, Francesco; Gentile, Massimo; Cox, Maria Christina; Vallisa, Daniele |
| 19 | Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment | 2011 | Morabito F; Gentile M; Mazzone C; Rossi D; Di Raimondo F; Bringhen S; Ria R; Offidani M; Patriarca F; Nozzoli C; Petrucci MT; Benevolo G; Vincelli I; Guglielmelli T; Grasso M; Marasca R; Baldini L; Montefusco V; Musto P; Cascavilla N; Majolino I; Musolino C; Cavo M; Boccadoro M; Palumbo A. |
| 20 | Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis | 2014 | Maccaferri, Monica; Leonardi, Giovanna; Marasca, Roberto; Colaci, Elisabetta; Paolini, Ambra; Soci, Francesco; Forghieri, Fabio; Potenza, Leonardo; Narni, Franco; Luppi, Mario |
Nome completo:
MARASCA, Roberto
Varianti:
Marasca R
Copyright © 2019